Dividend Stocks Icon

Dividend Stocks

Many investors overlook the importance of steady income. No matter your investment profile, dividends provide stable growth with consistent payments that accrue and compound over time. If you plan to retire wealthy, you need stocks that will pay you to own them. Our investment analysts highlight the stocks with the highest yields, uncover those increasing their payouts and evaluate the highly regarded Dividend Aristocrats, plus much more. Read on to find out how you can profit from investing in dividend stocks.

Recent Dividend Stocks Articles

9 All-Around Dividend Stocks to Tough It Out

The best dividend stocks offer viable options that vary by investment style ... but these stocks that pay dividends are for everyone!

5 Stocks to Buy That Have Steady Dividends and Earnings

5 stocks to buy that have steady dividends. These five stocks have steady dividend yields, good earnings prospects, are cheap and have huge upside.

Income Investors Need to Look Beyond BP Stock

With a dividend yield over 10%, BP stock looks like an attractive income pick. But that yield shows the market wisely is pricing in a dividend cut.

Is the Exxon Mobil Stock Dividend Safe?

The Exxon Mobil stock dividend appears to be safe for now, but the company's finances need significant improvement for it to stay that way.

BP Raises Billions, Buys More Time For Oil To Recover

BP ultimately needs higher oil prices to get to solid ground. For now its capital raise will be enough to keep things steady for BP stock.

While BP Stock Looks too Cheap to Pass On, There Could be Lower Lows Ahead

Investors in BP stock are likely to face a dividend cut in the near future, perhaps as soon as Q2 results.

Exxon Mobil Stock Is on the Way Back, but It Will Take Some Time

Exxon is starting to recover. However, investors will need to be patient -- low chemical and refining demand will slow Exxon's bounce.

3 of the Best Dividend Stocks to Buy Now

While growth investors may be less certain about an end-of-year rally for growth stocks, there are several good dividend stocks to consider.

BP Is Greenwashing Its Liquidation

BP CEO Bernard Looney says he's increasing his green energy budget and writing down oil assets, but what he's really doing is liquidating the company.

5 Cheap Growth Stocks With Attractive Dividend Yields

These cheap GARP stocks have huge upside potential with attractive yields, and wise investors should not ignore them.

7 Dividend Stocks On the Highway to the Danger Zone

Investors are scrambling for income now that savings rates have evaporated, but some dividend stocks are less secure than they seem.

Bank of America Has a Solid Dividend, But It Faces a New Threat

Big banks already had to suspend buybacks and dividends once, but will they resume in 2021? Keep a close eye on Bank of America stock.

Buy Conservative Chevron Stock for Its Big Dividend

Chevron stock will rally once oil demand rebounds. CVX management deserves credit for navigating the company ably in these troubled times.

A Buying Window May Be Opening for Energy Transfer

Energy Transfer has a juicy distribution yield of nearly 14%. Long-term and passive income investors may want to buy the dips in ET stock.

Exxon Mobil’s Opportunities Far Outweigh Its Threats

Given Exxon's dividend yield and valuation, along with rapidly increasing gasoline consumption, Exxon Mobil stock is still worth buying. 

Hold Wells Fargo Stock Even If a Dividend Cut Is Imminent

Investors don't need to worry about Wells Fargo stock even if the mega-bank is a dividend-cut candidate. Here's why.

Undervalued Energy Transfer Has Room to Run in 2020

Energy Transfer's huge yield is well covered by its distributable cash flow. Undervalued ET stock is worth at least 21% more.

Target Finds a Downside in Its Urban Strategy

Target stock fell after some of its stores were looted, while others are now closed. But its urban strategy remains sound for the long term.

Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk

Analysts call ABBV stock a bargain after its $63 billion purchase of Allergan, whose existing drugs and pipeline are now expected to replace revenue from Humira.